Ortho's miconazole nitrate 2%
Executive Summary
Ingredient will not appear in tentative final monograph on antifungal drug products, but data from Ortho will be considered prior to final monograph, FDA told the company in an Oct. 30 letter.
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
PS009267
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
PS009267
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.